Cardiovascular Systems (CSII) Reports In-Line Q3 EPS

Cardiovascular Systems (NASDAQ: CSII) reported Q3 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $52.1 million versus the consensus estimate of $51.13 million.

GUIDANCE:

Cardiovascular Systems sees Q4 2017 EPS of $0.06-($0.04). Cardiovascular Systems sees Q4 2017 revenue of $51.5-52.5 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Tesla to launch Cybercab in Austin this month - report